Now Reading
Impact of Achieving Global Access to Science for All in New Season of Science Will Tell Podcast by the Life Science Business of Merck KGaA, Darmstadt, Germany
Impact of Achieving Global Access to Science for All in New Season of Science Will Tell Podcast by the Life Science Business of Merck KGaA, Darmstadt, Germany
Published 09-30-22
Submitted by MilliporeSigma
The Science Will Tell podcast series from the Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, explores myriad solutions to sustainability and community impact.
During the podcast’s second season, listeners will hear tangible strategies for closing the Science, Technology, Engineering and Math (STEM) gender and diversity gaps, as well as the importance of providing scientific access to under-served and under-resourced communities around the globe. Guests include senior executives from the company, industry thought leaders and nonprofit and university partners.
In the first episode of season two, Dr. Glenn Hurst, associate professor at the University of York’s Green Chemistry Centre of Excellence, joins Jeffrey Whitford, head of sustainability & social business innovation, and Melissa Hackmeier, global head of employee & community engagement at the Life Science business of Merck KGaA, Darmstadt, Germany, to discuss:
- the importance of sparking scientific inquisitiveness in children at an early age with engaging hands-on education;
- the impact of fostering equal and equitable access to science education for underserved and underrepresented populations; and
- Dr. Hurst’s pioneering work in chemistry and Green Chemistry educational tools and research.
Listen to the episode here: https://sciencewilltell.podbean.com/.
MilliporeSigma
MilliporeSigma
We holistically integrate sustainability throughout our own operations and across suppliers, reducing the impact of scientific research globally and exceeding customer expectations.
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 26,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
Around 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck KGaA, Darmstadt, Germany, generated sales of € 21.2 billion in 65 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.
More from MilliporeSigma
